| | | |
| 08:00 - 08:30 | Opening Ceremony |
| Meeting Room 309 | |
| | | |
| 08:30
- 09:00 | State-of-the Art Lecture 1 |
| Meeting Room 309 | |
| SOTA 1 | 08:30 - 09:00 | Hospital setting: Infection control in the resistance era |
| | Wing-Hong
Seto, Hong Kong |
| | | |
| 09:15 - 10:45 | Concurrent Session 1 |
| Meeting Room 310 | Hepatitis C - Discovering Genomics |
| CS 1.1 | 09:15 - 09:35 | HCV genotypes in
hepatitis C patients and their clinical significances |
| | Jun Cheng, Beijing |
| | |
| CS 1.2 | 09:35 - 09:55 | Hepatitis C pharmacogenetics |
| | Golo Ahlenstiel, Sydney |
| | |
| CS 1.3 | 09:55 - 10:15 | Genomic-based treatment paradigms for patients with chronic
hepatitis C infection |
| | Alexander
J. Thompson, Melbourne |
| | |
| CS 1.4 | 10:15 - 10:35 | Association of IL28B
gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients |
| | Ching-Sheng Hsu, Taipei |
| | |
| 10:35 - 10:45 | Discussion |
| | | |
| 09:15
- 10:45 | Concurrent Session 2 |
| Meeting Room 311A | The Best of ECCMID 2011 |
| CS
2.1 | 09:15 - 09:45 | The Year in
Clinical Microbiology |
| | | Luis
Martinez Martinez, Santander |
| | | |
| CS 2.2 | 09:45 - 10:15 | The
Year in Infectious Diseases |
| | | Murat
Akova, Ankara |
| | | |
| | 10:15 - 10:45 | Discussion |
| | | |
| 09:15
- 10:45 | Concurrent Session 3 |
| Meeting Room 311B | Invasive Fungal Infection |
| CS 3.1 | 09:15 - 09:35 | Epidemiology and outcome of Candida bloodstream infection
in an intensive care unit in Hong Kong |
| | Mamie Hui, Hong Kong |
| | |
| CS 3.2 | 09:35 - 09:55 | Efficacy of common antifungal drugs |
| | TBC |
| | |
| CS 3.3 | 09:55 - 10:15 | Recent advances in management of cryptococcal
meningitis |
| | Tania
C. Sorrell, Sydney |
| | |
| CS 3.4 | 10:15 - 10:35 | Invasive fungal infections:
Diagnosis and treatments in China |
| | Yuping Ran, Chengdu |
| | |
| 10:35 - 10:45 | Discussion |
| | | |
| 10:45 - 11:15 | Poster Session / Coffee Break |
| | | |
| 11:15 - 11:45 | State-of-the
Art Lecture 2 |
| Meeting Room 309 | |
| SOTA 2 | 11:15 - 11:45 | Highlights
of the APASL Single Topic on HCV in Chiba |
| | Masao Omata, Tokyo |
| | | |
| 11:45 - 13:30 | Poster Session / Lunch |
| | | |
| 13:30 - 15:00 | Concurrent
Session 4 |
| Meeting Room 310 | Clinical Trials
for Hepatitis C - The Key Concepts with New Therapies |
| CS 4.1 | 13:30 - 13:50 | Personalized medicine for HCV treatment |
| | Ming-Lung Yu, Kaohsiung |
| | |
| CS 4.2 | 13:50 - 14:10 | Directly acting antivirals against HCV |
| | Xiaoguang Dou, Shenyang |
| | |
| CS 4.3 | 14:10 - 14:30 | Ursodeoxycholic acid treatment
for HCV patients |
| | Seung Up Kim, Seoul |
| | |
| CS 4.4 | 14:30 - 15:00 | Prepare for
the new therapies: Current status and policy in China |
| | Lai Wei, Beijing |
| | |
| 14:50 - 15:00 | Discussion |
| | | |
| 13:30 - 15:00 | Concurrent
Session 5 |
| Meeting Room 311A | Antimicrobial
Resistance |
| | |
| CS 5.3 | 14:10 - 14:30 | Respiratory infections
due to drug-resistant bacteria |
| | Doo Ryeon Chung, Seoul |
| | |
| CS 5.4 | 14:30 - 14:50 | Antimicrobial resistance in China |
| | Yonghong Xiao, Beijing |
| | |
| 14:50 - 15:00 | Discussion |
| | | |
| 13:30 - 15:00 | Concurrent
Session 6 |
| Meeting Room 311B | Vector-Borne
Infection |
| CS 6.1 | 13:30 - 13:50 | Malaria:
The challenge of resistance and hope of elimination |
| | Linhua Tang, Shanghai |
| | |
| CS 6.2 | 13:50 - 14:10 | Re-emergence of Chikungunya virus |
| | Yong Poovorawan, Bangkok |
| | |
| CS 6.3 | 14:10 - 14:30 | The status of antiviral development for dengue |
| | Subhash Vasudevan, Singapore |
| | |
| CS 6.4 | 14:30 - 15:00 | Climate and dengue infection |
| | Qiyong Liu, Beijing |
| | |
| 14:50 - 15:00 | Discussion |
| | | |
| 15:00 - 15:30 | Poster Session / Coffee Break |
| | | |
| 15:30 - 17:00 | General Session 1 |
| Meeting Room 309 | ESGARS-endorsed symposium |
| GS 1.1 | 15:30 - 15:50 | Management
of infections caused by MDR Gram-positives |
| | | Paolo Grossi, Varese |
| | | |
| GS 1.2 | 15:50 - 16:10 | Management of infections caused by MDR Gram-negatives |
| | | Murat Akova, Ankara |
| | | |
| GS 1.3 | 16:10
- 16:30 | Management of MDR TB |
| | | TBC (Chinese expert) |
| | | |
| GS 1.4 | 16:30
- 16:50 | Management of fungal infections |
| | | TBC (Chinese expert) |
| | | |
| | 16:50 - 17:10 | Discussion |
| | | |
| 15:30 - 17:00 | Free Paper Presentation 1 |
| Meeting Room 310 | Hepatitis C |
| | |
| 15:30 - 17:00 | Free Paper Presentation 2 |
| Meeting Room 311A | Antibiotics and Bacterial Infection |
| | |
| 15:30 - 17:00 | Free Paper Presentation 3 |
| Meeting Room 311B | Travel Medicine, Vector-Borne Diseases and Parasitic Infections |
| | |
| 17:15 - 18:15 | Abbott Day on Infectious Diseases |
| |
| | 17:15 - 17:45 | HCV Antigen: The future of HCV diagnosis |
| | | Fengmin Lu, Beijing |
| | | |
| | 17:45 - 18:15 | New marker in the HBeAg positive
CHB therapy monitoring |
| | | Jie
Xu |